Hamilton Enhanced Canadian Financials ETF (HFIN) News

https://appadvice.com/app/appysleep/6477474905

Four years ago we were the same price.

The dilutions and Linda's inability to partner have (past tense) destroyed all s/h value.

August 1st 2016 shares were the same as today. It's been 8 years ++ of nothing.

The true test will be what Linda does with an

Interesting properties

When it runs, hard to get shares

This can run quickly

"Since Nvidia remains the leading hardware producer for AI technology, increasing capex spend by its biggest customers bodes well for Nvidia's results."

Its capital expenditure, including finance leases, jumped 78% in the quarter to $19 billion, with Microsoft saying it needs to expan

Getting interesting

$8.88 Benny said

You're right, the "deep state" is used in conspiracy mode, but it isn't actually that.

The “deep state” is real. But it’s not what Trump thinks it is.

[...]

And Trump’s deep state obsession isn’t a new thing. He’s been pumping up this theory since speci

Last run shares where over a billion, now billions

RD Thanks! I am in no position to evaluate if estimates are conservative or not. But I note that estimates regarding the two first verticals have come down to one third of what they were. I take it that the banking groups will see to it that estimates are reasonably realistic to the extent that is

The shares outstanding scary

Who gets 0.0000001

Management drop some news

I want life saving new$$ $weet$$$

Interesting sales

Default now on the horizon, no collateral on debt, hell of a way to run a business.

How many reverse split in a matter of months, speculating

Finra act in their own time not ours unfortunately.

When is the next r s. Lol

We finda make some jingle here bubba

I'm positive janice would not be offended by your cooking. I grew up working in the food industry lol. If there was dough to be made it was a hundred pounds of it.

If there was sauce to be made, it was gallons of it. I'm a micro-manager now, pretty much always have been.

Wonder about drugs

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR): A Late-Stage Biopharma Poised for Potential Break-through:

https://beyondspx.com/2024/07/30/citius-pharmaceuticals-inc-nasdaqctxr-a-late-stage-biopharma-poised-for-potential-breakthroughs/